| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |